Kathleen Seyb

956 total citations
19 papers, 546 citations indexed

About

Kathleen Seyb is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Kathleen Seyb has authored 19 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Physiology. Recurrent topics in Kathleen Seyb's work include Alzheimer's disease research and treatments (5 papers), Complement system in diseases (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Kathleen Seyb is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Complement system in diseases (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Kathleen Seyb collaborates with scholars based in United States, Sweden and India. Kathleen Seyb's co-authors include Marcie A. Glicksman, Mary L. Michaelis, Sabah Ansar, Gregory D. Cuny, Li‐Ching Lai, Qiongman Kong, Kenneth L. Audus, Gunda I. Georg, Richard H. Himes and Kou Takahashi and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Kathleen Seyb

19 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Seyb United States 14 214 183 146 91 67 19 546
Andrea Loreto United Kingdom 16 373 1.7× 172 0.9× 108 0.7× 110 1.2× 114 1.7× 36 902
Serena Stanga Italy 17 384 1.8× 107 0.6× 237 1.6× 54 0.6× 53 0.8× 31 649
Keiichi Kadoyama Japan 13 272 1.3× 121 0.7× 115 0.8× 29 0.3× 58 0.9× 36 583
Loredana Spoerri Australia 11 293 1.4× 115 0.6× 248 1.7× 72 0.8× 118 1.8× 13 717
Juliet Rashidian Canada 9 471 2.2× 129 0.7× 148 1.0× 121 1.3× 81 1.2× 12 720
J. Christopher Hennings Germany 11 404 1.9× 182 1.0× 125 0.9× 177 1.9× 35 0.5× 16 846
Philipp Gobrecht Germany 11 339 1.6× 287 1.6× 53 0.4× 49 0.5× 52 0.8× 20 766
Sebastian Hogl Germany 11 347 1.6× 109 0.6× 303 2.1× 155 1.7× 147 2.2× 14 784
Ekaterini Copanaki Germany 11 366 1.7× 159 0.9× 251 1.7× 87 1.0× 18 0.3× 12 709
Xiang Yin China 17 350 1.6× 92 0.5× 90 0.6× 67 0.7× 134 2.0× 35 688

Countries citing papers authored by Kathleen Seyb

Since Specialization
Citations

This map shows the geographic impact of Kathleen Seyb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Seyb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Seyb more than expected).

Fields of papers citing papers by Kathleen Seyb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Seyb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Seyb. The network helps show where Kathleen Seyb may publish in the future.

Co-authorship network of co-authors of Kathleen Seyb

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Seyb. A scholar is included among the top collaborators of Kathleen Seyb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Seyb. Kathleen Seyb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Medjeral‐Thomas, Nicholas, Pritesh Trivedi, Kathleen Seyb, et al.. (2019). Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. Kidney International. 95(3). 655–665. 34 indexed citations
2.
Ricardo, Alonso, et al.. (2017). RA101495 abolishes residual complement activity observed in the presence of eculizumab. Molecular Immunology. 89. 189–189. 1 indexed citations
3.
Yang, Zijiang, John Concannon, Kelvin S. Ng, et al.. (2016). Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation. Scientific Reports. 6(1). 30263–30263. 25 indexed citations
4.
Manocha, Gunjan D., Kendra L. Puig, Susan A. Austin, et al.. (2015). Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis. PLoS ONE. 10(7). e0132604–e0132604. 14 indexed citations
5.
Ricardo, Alonso, Steven J. DeMarco, Robert E. Hammer, et al.. (2015). Preclinical Evaluation of RA101495, a Potent Cyclic Peptide Inhibitor of C5 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria. Blood. 126(23). 939–939. 27 indexed citations
6.
Pytel, Dariusz, Kathleen Seyb, Min Liu, et al.. (2014). Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors. SLAS DISCOVERY. 19(7). 1024–1034. 22 indexed citations
7.
Randhawa, Parmjeet, Gang Zeng, Marta Bueno, et al.. (2014). Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs. Antiviral Research. 112. 113–119. 10 indexed citations
8.
Kong, Qiongman, Ling‐Chu Chang, Kou Takahashi, et al.. (2014). Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. Journal of Clinical Investigation. 124(3). 1255–1267. 116 indexed citations
9.
Ricardo, Alonso, Steven J. DeMarco, Robert E. Hammer, et al.. (2014). Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases. Blood. 124(21). 2936–2936. 7 indexed citations
10.
Zeldich, Ella, Kathleen Seyb, Mickey Huang, et al.. (2012). Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization.. PubMed. 1(1). 75–87. 17 indexed citations
11.
Tang, Xiaohu, Kathleen Seyb, Mickey Huang, et al.. (2011). A High-Throughput Screening Method for Small-Molecule Inhibitors of the Aberrant Mutant SOD1 and Dynein Complex Interaction. SLAS DISCOVERY. 17(3). 314–326. 8 indexed citations
12.
Liu, Min, Shibu M. Poulose, Eli Schuman, et al.. (2010). Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2—Discovery of LRRK2 inhibitors. Analytical Biochemistry. 404(2). 186–192. 24 indexed citations
13.
Colton, Craig K., Qiongman Kong, Li‐Ching Lai, et al.. (2010). Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity. SLAS DISCOVERY. 15(6). 653–662. 65 indexed citations
14.
Qiao, Lixin, Sung‐Woon Choi, April Case, et al.. (2009). Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(21). 6122–6126. 22 indexed citations
15.
Seyb, Kathleen, et al.. (2008). Identification of Small Molecule Inhibitors of β-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform. SLAS DISCOVERY. 13(9). 870–878. 14 indexed citations
16.
Seyb, Kathleen, et al.. (2007). p35/Cyclin-dependent kinase 5 is required for protection against β-amyloid-induced cell death but not tau phosphorylation by ceramide. Journal of Molecular Neuroscience. 31(1). 23–35. 6 indexed citations
17.
Seyb, Kathleen, et al.. (2006). β-Amyloid and Endoplasmic Reticulum Stress Reponses in Primary Neurons: Effects of Drugs That Interact With the Cytoskeleton. Journal of Molecular Neuroscience. 28(2). 111–124. 40 indexed citations
18.
Michaelis, Mary L., Sabah Ansar, Kathleen Seyb, et al.. (2005). β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents. Journal of Pharmacology and Experimental Therapeutics. 312(2). 659–668. 78 indexed citations
19.
Michaelis, Mary L., Kathleen Seyb, & Sabah Ansar. (2005). Cytoskeletal Integrity as a Drug Target. Current Alzheimer Research. 2(2). 227–229. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Loreto Breakdown of academic impact, for papers by Serena Stanga Breakdown of academic impact, for papers by Keiichi Kadoyama Breakdown of academic impact, for papers by Loredana Spoerri Breakdown of academic impact, for papers by Juliet Rashidian Breakdown of academic impact, for papers by J. Christopher Hennings Breakdown of academic impact, for papers by Philipp Gobrecht Breakdown of academic impact, for papers by Sebastian Hogl Breakdown of academic impact, for papers by Ekaterini Copanaki Breakdown of academic impact, for papers by Xiang Yin
Rankless by CCL
2026